title: Current perspectives on respiratory syncytial virus infection.
abstract: Respiratory syncytial virus (RSV) is the most important cause of acute viral bronchiolitis and pneumonia in infants and children. Management of RSV infection has changed dramatically over the past 5 to 7 years because of (1) the advent of widely available rapid tests for its specific identification and (2) use of the antiviral agent ribavirin (Virazole). Although RSV infection remains a life-threatening disease, particularly in certain high-risk groups, appropriate management and judicious use of ribavirin should help physicians reduce its morbidity and mortality.
authors.affiliation: University of North Dakota School of Medicine, Fargo.
authors.forename: R J
authors.initials: RJ
authors.lastname: Kuzel
authors.forename: D J
authors.initials: DJ
authors.lastname: Clutter
mesh_terms: D000336:Aerosols; D000553:Ambulatory Care; D000998:Antiviral Agents / Q000008:administration & dosage; D001990:Bronchiolitis, Viral / Q000175:diagnosis / Q000628:therapy; D003428:Cross Infection / Q000517:prevention & control; D006760:Hospitalization; D006801:Humans; D007223:Infant; D012136:Respiratory Syncytial Viruses; D010253:Respirovirus Infections / Q000175:diagnosis / Q000628:therapy / Q000635:transmission; D012307:Risk Factors
chemical_list: D000336:Aerosols; D000998:Antiviral Agents